Impact of the extent of axillary surgery in patients with N2-3 disease in the de-escalation era: a propensity score-matched study.
Y KongA YangX XieJ ZhangH XuM LiNing LyuW WeiPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2020)
Additional level-III dissection has a limited impact on survival but still valuable in an accurate stage. The reduction of surgeries in axillary should be treated with discretion in breast cancer patients with a heavy axillary burden.
Keyphrases
- lymph node
- sentinel lymph node
- neoadjuvant chemotherapy
- ultrasound guided
- minimally invasive
- early stage
- coronary artery bypass
- open label
- high resolution
- locally advanced
- squamous cell carcinoma
- clinical trial
- risk factors
- radiation therapy
- randomized controlled trial
- coronary artery disease
- atrial fibrillation
- acute coronary syndrome
- mass spectrometry
- study protocol
- rectal cancer